Prisoners' views of injecting drug use and harm reduction in Irish prisons

International Journal of Drug Policy

Volumn 15, Issue 2, 2004, Pages 139-149

  Long, Jean ^a,c   Allwright, Shane ^a   Begley, Cecily ^b  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

^c HEALTH RESEARCH BOARD   (Ireland)

Author keywords

Blood borne viruses; Harm reduction; Injecting drug use; Prisoners

Indexed keywords

DIAMORPHINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEALTH HAZARD; HEPATITIS; HUMAN; INTERVIEW; INTRAVENOUS DRUG ABUSE; IRELAND; PRIORITY JOURNAL; PRISONER; PUBLIC HEALTH SERVICE; QUALITATIVE ANALYSIS; RISK ASSESSMENT; RISK REDUCTION;

EID: 1642360769     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3959(03)00090-2     Document Type: Article

References (44)

1. Allwright, S., Barry, J., Bradley, F., Long, J., & Thornton, L. (1999). Hepatitis B, hepatitis C and HIV in Irish prisoners: Prevalence and risk. Dublin: The Stationery Office.
2. Allwright S., Bradley F., Long J., Barry J., Thornton L., Parry J.V. Prevalence of antibodies to hepatitis B, hepatitis C and HIV and risk factors in Irish prisoners: Results of a national cross sectional survey. British Medical Journal. 321:2000;78-82.
3. Appleton J. Analysing qualitative interview data: Addressing issues of validity and reliability. Journal of Advanced Nursing. 22:1995;993-997.
4. Bird A., Gore S., Cameron S., Ross A., Goldberg D. Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie. AIDS. 9(7):1995;801-808.
5. Bird A., Gore S., Jolliffe D., Burns S. Anonymous HIV surveillance in Soughton Prison, Edinburgh. AIDS. 6(7):1992;725-773.
6. Branigan, P., Hillsdon, M., & Wellings, K. (2000). An evaluation of the feasibility of introducing harm reduction techniques into prisons in England and Wales. Encouraging Health Promotion for Drug Users within the Criminal Justice System Conference incorporating the Fourth European Conference of Drug and HIV/AIDS Services in Prison. Hamburg, Germany.
7. Carvell A., Hart G. Risk behaviours for HIV infection among drug users in prison. British Medical Journal. 300:1990;1383-1384.
8. Crofts N., Stewart T., Hearne P., Ping X.Y., Breschkin A.M., Locarnini S.A. Spread of blood-borne viruses among Australian prison entrants. British Medical Journal. 310:1995;285-288.
9. Darke S., Kaye S., Finlay-Jones R. Drug use and injection risk-taking among prison methadone maintenance patients. Addiction. 93(8):1998;1169-1175.
10. Denzin, N. (1989). The research act: A theoretical introduction to sociological methods. New York: McGraw Hill.
11. Dillon, L. (2001). Drug use among prisoners: An exploratory study. Dublin: The Health Research Board.
12. Dolan K., Hall W., Wodak A. Methadone maintenance reduces injecting in prison. British Medical Journal. 312:1996;1162.
13. Dolan, K., Hall, W., & Wodak, A. (1998). The provision of methadone within prison settings. In J. Ward, R. P. Mattick, & W. Hall (Eds.), Methadone maintenance treatment and other opioid replacement therapies (pp. 379-395). Amsterdam: Harwood Academic Publishers.
14. Dolan K., Rutter S., Wodak A.D. Prison based syringe exchange programmes: A review of international research and development. Addiction. 98:2003;153-158.
15. Dolan, K., Wodak, A., Mattick, R., & Hall, W. (2000). A randomised control trial of the New South Wales prison methadone programme. Encouraging Health Promotion for Drug Users within the Criminal Justice System Conference incorporating the Fourth European Conference of Drug and HIV/AIDS Services in Prison. Hamburg, Germany.
16. European Monitoring Centre for Drugs and Drug Addiction. (2000). An overview on substitution treatment. In Reviewing current practice in drug substitution treatment in the European Union (pp. 135-145). Luxembourg: Office for Official Publications of the European Union.
17. Farrell, M., Howes, S., Vester, A., & Davoli, M. (1999). Reviewing current practice in drug substitution treatment in Europe. London, Lisbon, Rome: National Addiction Centre, EMCDDA, Osservatorio Epidemiologico.
18. Goldberg D., Cameron S., McMenamin J. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high. Communicable Disease and Public Health. 1(2):1998;95-97.
19. Goldberg D., Taylor A., McGregor J., Davis B., Wrench J., Gruer L. A lasting public health response to an outbreak of HIV infection in a Scottish prison? International Journal of STD and AIDS. 9(1):1998;25-30.
20. Gore S., Bird A., Burns S., Goldberg D., Ross A., Macgregor J. Drug injection and HIV prevalence in inmates of Glenochill prison. British Medical Journal. 310:1995;293-296.
21. Gore S., Bird A., Burns S., Ross A., Goldberg D. Anonymous HIV surveillance with risk-factors elicitation: At Perth (for men) and Cornton Vale (for women) prisons in Scotland. International Journal of STD and AIDS. 8:1997;166-175.
22. Haber P., Parsons S., Harper S., White P., Rawlinson W., Lloyd A. Transmission of hepatitis C within Australian prisons. Medical Journal of Australia. 171(1):1999;31-33.
23. Hurley S.F., Jolley D.J., Kaldor J.M. Effectiveness of needle exchange programmes for prevention of HIV infection. The Lancet. 349:1997;1797-1800.
24. Hutchinson S., Goldberg D., Gore S., Cameron S., McGregor J., McMenamin J., McGavigan J. Hepatitis B outbreak at Glenochil prison during January to June 1993. Epidemiology and Infection. 121(1):1998;185-191.
25. Irish Prison Service. (2000). Report of the steering group on prison based drug treatment services. Dublin: Department of Justice, Equality and Law Reform.
26. Kent H. Should prisons ease drug prohibition to help reduce disease spread? Canadian Medical Association Journal. 155(10):1996;1489-1491.
27. Koch T. Establishing rigour in qualitative research: The decision trail. Journal of Advanced Nursing. 19:1994;976-986.
28. Long, J., Allwright, S., Barry, J., Reaper-Reynolds, S., Thornton, L., & Bradley, F. (2000). Hepatitis B, hepatitis C, and HIV in Irish prisoners: Part II. Prevalence and risks in committal prisoners 1999. Dublin: The Stationery Office.
29. Long J., Allwright S., Barry J., Reaper-Reynolds S., Thornton L., Bradley F., Parry J. Hepatitis B, hepatitis C and HIV antibodies prevalence and risk factors in entrants to Irish prisons: A national survey. British Medical Journal. 323:2001;1209-1211.
30. Malliori M., Sypsa V., Psichogiou M., Touloumi G., Skoutelis A., Tassopoulos N., Hatzakis A., Stefanis C. A survey of blood borne viruses and associated risk behaviours in Greek prisons. Addiction. 93(2):1998;243-251.
31. Mariano, C. (1995). The qualitative research process. In Principles and practice of nursing research (pp. 463-491). Talbot. L. Missouri: Mosby-Year Book Inc.
32. Marsch L. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behaviour and criminality: A meta-analysis. Addiction. 93(4):1998;515-532.
33. Nelles J., Fuhrer A., Hirsbruhher H., Harding T. Provision of syringes: The cutting edge of harm reduction in prison. British Medical Journal. 317:1998;270-273.
34. O'Mahony, P. (1997). Mountjoy prisoners a sociological and criminological profile. Dublin: Department of Justice.
35. Poland, B. (1999). Transcription quality as an aspect of rigor in qualitative research. In A. Bryman & R. Burgess (Eds.), Qualitative research: Part 3. Analysis and interpretation of qualitative data (pp. 13-32). London: Sage.
36. Polit, D., & Hungler, B. (1999). Nursing research-principles and methods. Philadelphia: Lippincott.
37. Seidel, J. (1998). The ethnograph version 5.0. Thousand Oaks: Sage.
38. Smyth B., Keenan E., O'Connor J.J. Evaluation of the impact of Dublin's expanded harm reduction programme on prevalence of hepatitis C among short term injecting drug users. Journal of Epidemiology and Community Health. 53:1999;434-435.
39. Smyth B., Langkamp H., Schmid M., Green S., Mckendrick M., McCarthy N. Health effects in prison. British Medical Journal. 321:2000;1406-1407.
40. Streubert Speziale, H. J., & Rinaldi Carpenter, D. (2003). Qualitative research in nursing: Advancing the humanistic imperative. Philadelphia: Lippincott.
41. Taylor A., Goldberg D., Emslie J., Wrench J., Gruer L., Cameron S., Black J., Davis B., McGregor J., Follett E., Harvey J., Basson J., McGavigan J. Outbreak of HIV infection in a Scottish prison. British Medical Journal. 310:1995;289-292.
42. Thornton L., Barry J., Long J., Allwright S., Bradley F., Parry J. Comparison between self reported hepatitis B, hepatitis C and HIV antibody status and oral fluid assay results in Irish prisoners. Communicable Disease and Public Health. 3(4):2000;253-255.
43. Turnbull, P. J., Dolan, K. A., & Stimson, G. V. (1991). Prisons HIV and AIDS: Risks and experiences in custodial care. Horsham: AVERT.
44. Turnbull, P. J., Stimson, G. V., & Stillwell, G. (1994). Drug use in prison. Horsham: AVERT.